These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18685594)

  • 1. Predicting the future for people with lung cancer.
    Xie Y; Minna JD
    Nat Med; 2008 Aug; 14(8):812-3. PubMed ID: 18685594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A commentary on 'Identification of the consistently differential expressed hub mRNAs and proteins in lung adenocarcinoma and construction of the prognostic signature: a multidimensional analysis'.
    Sindya J; Perumal E; Gunasekaran K
    Int J Surg; 2024 Jul; 110(7):4516-4517. PubMed ID: 38573114
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular testing in lung carcinoma: Quo vadis?
    Dacic S; Yousem SA
    Am J Clin Pathol; 2010 Jul; 134(1):7-9. PubMed ID: 20551260
    [No Abstract]   [Full Text] [Related]  

  • 4. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
    Robles AI; Arai E; Mathé EA; Okayama H; Schetter AJ; Brown D; Petersen D; Bowman ED; Noro R; Welsh JA; Edelman DC; Stevenson HS; Wang Y; Tsuchiya N; Kohno T; Skaug V; Mollerup S; Haugen A; Meltzer PS; Yokota J; Kanai Y; Harris CC
    J Thorac Oncol; 2015 Jul; 10(7):1037-48. PubMed ID: 26134223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
    Deng B; Sun Z; Jason W; Yang P
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-dependent regulation of transcription in non-small cell lung cancer.
    Molina-Pinelo S; Gutiérrez G; Pastor MD; Hergueta M; Moreno-Bueno G; García-Carbonero R; Nogal A; Suárez R; Salinas A; Pozo-Rodríguez F; Lopez-Rios F; Agulló-Ortuño MT; Ferrer I; Perpiñá A; Palacios J; Carnero A; Paz-Ares L
    PLoS One; 2014; 9(3):e90524. PubMed ID: 24625834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the ABCE1 gene in human lung adenocarcinoma.
    Ren Y; Li Y; Tian D
    Oncol Rep; 2012 Apr; 27(4):965-70. PubMed ID: 22267055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
    Chen G; Gharib TG; Huang CC; Thomas DG; Shedden KA; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Clin Cancer Res; 2002 Jul; 8(7):2298-305. PubMed ID: 12114434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation.
    Wang JL; Lu FZ; Shen XY; Wu Y; Zhao LT
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):229-33. PubMed ID: 25449277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.
    Zhang J; Ni SS; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Aug; 34(4):2397-401. PubMed ID: 23595221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
    Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.
    Hsu MK; Wu IC; Cheng CC; Su JL; Hsieh CH; Lin YS; Chen FC
    Oncotarget; 2015 Oct; 6(30):28755-73. PubMed ID: 26356813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of MicroRNA in Lung Cancer.
    Wu KL; Tsai YM; Lien CT; Kuo PL; Hung AJ
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30935143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug is associated with poor survival in squamous cell carcinoma of the lung.
    Merikallio H; T TT; Pääkkö P; Mäkitaro R; Kaarteenaho R; Lehtonen S; Salo S; Salo T; Harju T; Soini Y
    Int J Clin Exp Pathol; 2014; 7(9):5846-54. PubMed ID: 25337226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
    Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approach.
    Chen L; Huang T; Zhang YH; Jiang Y; Zheng M; Cai YD
    Sci Rep; 2016 Jul; 6():29849. PubMed ID: 27412431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.